LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Arthur Klausner to speak at the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) in Boston, MA
News | 08. 04. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.